IFNA1 and neoplasm: Recent findings have established that epigenetic drugs and targeted compounds that lead to acute IFN activation showed impressive tumour suppression, infiltration of anti-tumour immune cells [23, 35, 36], as well as increased sensitivity to immune checkpoint blockade [35, 60, 61].